Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Philpott

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Stem Cell Reports|November 4, 2022
BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogrammingKenan Sevinç, Gülben Gürhan Sevinç, Ayşe Derya Cavga, et al.
Journal of Medicinal Chemistry|March 24, 2015
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2BPeiling Chen, Apirat Chaikuad, Paul Bamborough, et al.
Journal of Medicinal Chemistry|October 26, 2012
Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hitPaul V Fish, Panagis Filippakopoulos, Gerwyn Bish, et al.
Cell Death & Disease|August 16, 2022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilitiesOzlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinomaYuliang Feng, Liuyang Cai, Martin Pook, et al.
Angewandte Chemie (International Ed. in English)|May 14, 2014
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interactionTimothy P C Rooney, Panagis Filippakopoulos, Oleg Fedorov, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Science Advances|December 25, 2015
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenanceOleg Fedorov, Josefina Castex, Cynthia Tallant, et al.
Cell Communication and Signaling : CCS|November 17, 2023
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, et al.
Nature Chemical Biology|May 24, 2016
Structural analysis of human KDM5B guides histone demethylase inhibitor developmentCatrine Johansson, Srikannathasan Velupillai, Anthony Tumber, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Stem Cell Reports|November 4, 2022
BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogrammingKenan Sevinç, Gülben Gürhan Sevinç, Ayşe Derya Cavga, et al.
Journal of Medicinal Chemistry|March 24, 2015
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2BPeiling Chen, Apirat Chaikuad, Paul Bamborough, et al.
Journal of Medicinal Chemistry|October 26, 2012
Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragment-derived hitPaul V Fish, Panagis Filippakopoulos, Gerwyn Bish, et al.
Cell Death & Disease|August 16, 2022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilitiesOzlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinomaYuliang Feng, Liuyang Cai, Martin Pook, et al.
Angewandte Chemie (International Ed. in English)|May 14, 2014
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interactionTimothy P C Rooney, Panagis Filippakopoulos, Oleg Fedorov, et al.
Journal of the American Chemical Society|June 20, 2014
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomainsDuncan A Hay, Oleg Fedorov, Sarah Martin, et al.
Science Advances|December 25, 2015
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenanceOleg Fedorov, Josefina Castex, Cynthia Tallant, et al.
Cell Communication and Signaling : CCS|November 17, 2023
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, et al.
Nature Chemical Biology|May 24, 2016
Structural analysis of human KDM5B guides histone demethylase inhibitor developmentCatrine Johansson, Srikannathasan Velupillai, Anthony Tumber, et al.
Pageof 8